$Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease$

Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease

Background: High-flow nasal cannula (HFNC) oxygen therapy provides effective respiratory management in patients with hypoxemic respiratory failure. However, the efficacy and tolerability of HFNC for patients with acute exacerbation of interstitial lung disease (AE-ILD) have not been established. Thi...

Full description

Bibliographic Details
Main Authors:	Takafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto, Hirotsugu Hasegawa, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Takafumi Suda
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-02-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753466620906327

Similar Items

The importance of high flow nasal cannula (HFNC) oxygen therapy
by: TIGLIS Mirela, et al.
Published: (2019-03-01)

Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
by: Takafumi Koyauchi, et al.
Published: (2022-04-01)

Highly fruitful nasal cannula: An innovative use of high flow nasal cannula (HFNC) and a lesson
by: Sumit Roy Chowdhury, et al.
Published: (2022-01-01)

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
by: Yuzo Suzuki, et al.
Published: (2023-07-01)

Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
by: Yuko Tanaka, et al.
Published: (2022-06-01)

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
by: Takahito Suzuki, et al.
Published: (2021-04-01)

Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
by: Masato Karayama, et al.
Published: (2021-12-01)

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
by: Keigo Koda, et al.
Published: (2021-01-01)

Comparison of CPAP and HFNC in Management of Bronchiolitis in Infants and Young Children
by: Majken Bisgaard Pedersen, et al.
Published: (2017-04-01)

Real-Time Optimal Flow Setting and Respiratory Profile Evaluation in Infants Treated with High-Flow Nasal Cannula (HFNC)
by: Francesco Montecchia, et al.
Published: (2024-04-01)

Therapeutic Outcome of High Flow Nasal Cannula (HFNC) for Severe COVID-19 Patients in Isolation Intensive Care Unit
by: Baginda Aflah, et al.
Published: (2023-06-01)

Role of high flow nasal cannula (HFNC) for pre-oxygenation among pregnant patients: Current evidence and review of literature
by: Ajay Singh, et al.
Published: (2022-01-01)

Predictors of success of high flow nasal cannula (HFNC) therapy in children with respiratory distress in pediatric intensive care unit
by: A V Lalitha, et al.
Published: (2018-01-01)

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
by: Yuzo Suzuki, et al.
Published: (2021-07-01)

3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitis
by: Shusuke Yazawa, et al.
Published: (2025-01-01)

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
by: Yuya Aono, et al.
Published: (2020-09-01)

High Flow Nasal Cannula Oxygen Therapy (HFNC) With Different Temperatures in COVID-19 Patients: A Randomized Clinical Trial
by: Maryam Sadat Mirenayat, et al.
Published: (2024-01-01)

The Evaluation of COVID-19 Patients Treated with HFNC in Intensive Care Unit
by: Ayşe Müge Karcıoğlu, et al.
Published: (2022-09-01)

Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis
by: Yuzo Suzuki, et al.
Published: (2023-05-01)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
by: Hironao Hozumi, et al.
Published: (2018-01-01)

Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
by: Hironao Hozumi, et al.
Published: (2024-07-01)

Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
by: Daisuke Akahori, et al.
Published: (2021-07-01)

The Use of Modified High Flow Nasal Cannula (HFNC) In Preterm Infants With Neonatal Respiratory Distress Syndrome (NRSD) In Primary ICU Services
by: Akhyar Nur Uhud, et al.
Published: (2021-07-01)

Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
by: Takahito Suzuki, et al.
Published: (2022-07-01)

Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation
by: Hirofumi Watanabe, et al.
Published: (2022-01-01)

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
by: Yasutaka Mochizuka, et al.
Published: (2022-01-01)

The Effectiveness Of High-Flow Nasal Cannula (HFNC) Therapy On Improvement Of Oxygen Saturation With Acute Breathing Failure In Covid-19 Patients (Literature Study)
by: Syafruddin Ali Salaka, et al.
Published: (2022-04-01)

Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
by: Koichi Miyashita, et al.
Published: (2023-12-01)

Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza
by: Koichi Miyashita, et al.
Published: (2025-02-01)

Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
by: Koichi Miyashita, et al.
Published: (2024-02-01)

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
by: Yoichiro Aoshima, et al.
Published: (2021-02-01)

Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung
by: Shogo Sakurai, et al.
Published: (2021-07-01)

The optimal management of the patient with COVID‐19 pneumonia: HFNC, NIV/CPAP or mechanical ventilation?
by: A G B Broadhurst, et al.
Published: (2022-10-01)

High flow nasal cannula (HFNC) and video laryngoscope (VL) as essential adjuncts in management of obstetric difficult airway: Efficacious tools or simply an industry push!
by: Anjan Trikha, et al.
Published: (2022-01-01)

Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.
by: Katsuhiro Yoshimura, et al.
Published: (2018-01-01)

CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung
by: Fumiya Nihashi, et al.
Published: (2024-07-01)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
by: Noriyuki Enomoto, et al.
Published: (2020-06-01)

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
by: Yuzo Suzuki, et al.
Published: (2018-09-01)

Pneumothorax in connective tissue disease-associated interstitial lung disease.
by: Koji Nishimoto, et al.
Published: (2020-01-01)

Clinical efficacy and safety of high-flow nasal cannula (HFNC) in acute hypoxaemic patients with COVID-19: a protocol for a systematic review and meta-analysis
by: Lei Yang, et al.
Published: (2022-04-01)